A growing industry is racing to engineer a solution to global warming using the absorbent power of the oceans.

Dozens of companies and academic groups are pitching the same theory: that sinking rocks, nutrients, crop waste or seaweed in ...

Cantor Fitzgerald lowered the firm’s price target on Nova (NVMI) to $300 from $315 and keeps an Overweight rating on the shares. Nova offered few surprises at its Virtual Analyst Day ...

Canada’s Fraser Institute says bans on hydraulic fracturing have led to billions of dollars’ worth of shale gas potential in both Nova Scotia and New Brunswick going undeveloped. In a new report, the ...

Employees at the National Cancer Institute, which is part of the National Institutes of Health, received internal guidance last week to flag manuscripts, presentations or other communications for ...

Scotiabank promises to disclose energy finance ratio in 2026Weeks after leaving the UN-backed Net-Zero Banking Alliance, the Bank of Nova Scotia has promised to ... fund PFA forsikringsaktieselskab ...

That is why nova-Institute is proud to welcome Dr. Lars Börger as the new Co-CEO alongside with Michael Carus, the current CEO of nova-Institute. As a team, they will join forces to drive progress ...

Lars Börger, Ph.D., has been appointed the new co-CEO of nova-Institute. Börger will serve as co-CEO alongside nova-Institute’s current CEO, Michael Carus. He officially started his role on March 1.

On October 7, she traveled with a close friend to the Nova music festival, where both were murdered. Every week, her father, Vladislav, visited her white grave and placed red roses on it.

Shares of Sunnova Energy International (NOVA) have plunged 60% on March 3 after the solar power company warned about its ability to continue as a going concern. See what stocks are receiving ...

Lars Börger will join nova-Institute as its new co-CEO on March 1, 2025. He will work alongside Michael Carus, the current CEO, to promote sustainability in the chemical and materials sectors.

Researchers at the University of Jyväskylä, in collaboration with the University of Turku's Institute of Biomedicine, University of Helsinki and Nova Hospital of Central Finland, have developed ...